Medicare Enrolled

Dr. Monika Mohan, M.D.

Rheumatology · Okemos, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2375 WOODLAKE DR STE 300, Okemos, MI 48864
5179083600
In practice since 2007 (19 years)
NPI: 1295852895 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mohan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mohan

Dr. Monika Mohan is a rheumatology specialist in Okemos, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mohan performed 39,380 Medicare services across 1,013 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mohan received a total of $180,245 from 40 pharmaceutical and/or device companies across 1153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mohan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in MI $180,245 industry payments

Medicare Practice Summary

Medicare Utilization ↗
39,380
Medicare services
Top 10% in MI for rheumatology
1,013
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,073 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
19,200 $10 $21
Romosozumab injection (Evenity) for osteoporosis 7,770 $8 $11
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
7,300 $33 $65
Denosumab injection (Prolia/Xgeva) 3,360 $18 $25
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
491 $84 $134
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
308 $95 $233
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
288 $1 $3
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
163 $56 $95
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
129 $10 $35
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
68 $115 $207
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
61 $12 $40
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
55 $21 $50
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
52 $1 $2
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
41 $29 $30
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
33 $74 $75
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
30 $8 $16
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
17 $48 $127
Virtual check-in for established patient
A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in.
14 $9 $90
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
68.1% high complexity
29.9% medium
2.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$180,245
Total received (2018-2024)
Avg $25,749/year across 7 years
Top 5% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
1,153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166,530 (92.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,182 (6.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,533 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,147
2023
$10,440
2022
$3,199
2021
$1,960
2020
$21,296
2019
$73,858
2018
$59,344

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$6,729
Janssen Biotech, Inc.
$1,533
UCB, Inc.
$369
AstraZeneca Pharmaceuticals LP
$272
ABBVIE INC.
$272
Novartis Pharmaceuticals Corporation
$251
PFIZER INC.
$143
E.R. Squibb & Sons, L.L.C.
$139
Fresenius Kabi USA, LLC
$82
Lilly USA, LLC
$70
Organon Llc
$44
Fidia Pharma USA Inc.
$41
SOBI, INC
$37
Genentech USA, Inc.
$33
Alexion Pharmaceuticals, Inc.
$24
HOSPIRA, INC.
$22
Kiniksa Pharmaceuticals International, plc
$21
GENZYME CORPORATION
$20
Alvogen Inc
$16
Aurinia Pharma U.S., Inc.
$15
Radius Health, Inc.
$14
Top 3 companies account for 85.1% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$50,307
Novartis Pharmaceuticals Corporation
$32,938
Janssen Scientific Affairs, LLC
$32,454
Amgen Inc.
$30,542
AbbVie, Inc.
$18,635
Janssen Biotech, Inc.
$3,590
AbbVie Inc.
$3,068
UCB, Inc.
$1,974
PFIZER INC.
$1,083
E.R. Squibb & Sons, L.L.C.
$1,048
ABBVIE INC.
$723
Genentech USA, Inc.
$672
AstraZeneca Pharmaceuticals LP
$545
GlaxoSmithKline, LLC.
$542
Lilly USA, LLC
$464
Horizon Therapeutics plc
$242
Radius Health, Inc.
$167
Regeneron Healthcare Solutions, Inc.
$142
Aurinia Pharma U.S., Inc.
$122
Actelion Pharmaceuticals US, Inc.
$119
Fresenius Kabi USA, LLC
$115
Sobi, Inc
$81
Antares Pharma, Inc.
$70
Alvogen Inc
$66
Alexion Pharmaceuticals, Inc.
$62
SOBI, INC
$60
Horizon Pharma plc
$54
Organon Llc
$44
GENZYME CORPORATION
$42
Fidia Pharma USA Inc.
$41
Gilead Sciences, Inc.
$37
Exeltis, USA Inc.
$37
Organon LLC
$32
ANI Pharmaceuticals, Inc.
$24
HOSPIRA, INC.
$22
Kiniksa Pharmaceuticals International, plc
$21
Mallinckrodt LLC
$19
Biocon Biologics Inc
$16
Sandoz Inc.
$13
MEDAC PHARMA, INC.
$12
Top 3 companies account for 64.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPSUMIT · ORENCIA · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UPTRAVI · XELJANZ · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for rheumatology in MI.

Looking for a rheumatology specialist in Okemos?
Compare rheumatologists in the Okemos area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
8
Per 100K population
2.8
County median income
$64,354
Nearest hospital
BRIGHTWELL BEHAVIORAL HEALTH
5.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mohan is a mixed practice specialist, with above-average Medicare volume (top 10% in MI), with speaking/promotional industry engagement in the top 5% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mohan experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Mohan performed 19,200 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohan receive payments from pharmaceutical companies?
Yes. Dr. Mohan received a total of $180,245 from 40 companies across 1,153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohan's costs compare to other rheumatologists in Okemos?
Dr. Mohan's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →